Variant report
Variant | esv3358384 |
---|---|
Chromosome Location | chr3:159812458-159816056 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:19)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:19 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr3:159813300-159813450 | GM12870 | blood: | n/a | n/a |
2 | EP300 | chr3:159812359-159812811 | HepG2 | liver: | n/a | n/a |
3 | FOS | chr3:159816053-159816282 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr3:159816050-159816226 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr3:159816036-159816262 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOXA1 | chr3:159812439-159812752 | HepG2 | liver: | n/a | n/a |
7 | FOXA1 | chr3:159812454-159812774 | HepG2 | liver: | n/a | n/a |
8 | FOXA1 | chr3:159812361-159812683 | HepG2 | liver: | n/a | n/a |
9 | FOXA1 | chr3:159812392-159812729 | HepG2 | liver: | n/a | n/a |
10 | FOXA2 | chr3:159812434-159812670 | HepG2 | liver: | n/a | n/a |
11 | MAX | chr3:159812441-159812811 | HepG2 | liver: | n/a | n/a |
12 | MAX | chr3:159812583-159812673 | HepG2 | liver: | n/a | n/a |
13 | MAX | chr3:159814683-159814696 | NB4 | blood: | n/a | n/a |
14 | NR2F2 | chr3:159812365-159812759 | HepG2 | liver: | n/a | n/a |
15 | NR2F2 | chr3:159812244-159812861 | HepG2 | liver: | n/a | n/a |
16 | RXRA | chr3:159812361-159812683 | HepG2 | liver: | n/a | chr3:159812627-159812646 |
17 | SP1 | chr3:159812362-159812758 | HepG2 | liver: | n/a | n/a |
18 | STAT3 | chr3:159813497-159813635 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | ZEB1 | chr3:159812369-159812855 | HepG2 | liver: | n/a | chr3:159812700-159812707 |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:159814166..159816690-chr3:159817105..159819056,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
BRD7P2 | TF binding region |
ENSG00000184100 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568199102 | chr3:159812484-159812485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533433234 | chr3:159812615-159812616 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76104209 | chr3:159812672-159812673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551496618 | chr3:159812775-159812776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535469881 | chr3:159812820-159812821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4680553 | chr3:159812905-159812906 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs75557420 | chr3:159812906-159812907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555740393 | chr3:159812914-159812915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201606716 | chr3:159812973-159812974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs137917555 | chr3:159812992-159812993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567551961 | chr3:159812997-159812998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76645726 | chr3:159813032-159813033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74366328 | chr3:159813071-159813072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190189673 | chr3:159813082-159813083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4680554 | chr3:159813096-159813097 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs553491948 | chr3:159813122-159813123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571755674 | chr3:159813123-159813124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375154925 | chr3:159813129-159813130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs114592242 | chr3:159813136-159813137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562076034 | chr3:159813151-159813152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529521102 | chr3:159813166-159813167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539788074 | chr3:159813177-159813178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558426108 | chr3:159813230-159813231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576739709 | chr3:159813268-159813269 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562429659 | chr3:159813269-159813270 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143384901 | chr3:159813272-159813273 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147332031 | chr3:159813307-159813308 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551898005 | chr3:159813375-159813376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79882799 | chr3:159813382-159813383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527723572 | chr3:159813416-159813417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192780975 | chr3:159813443-159813444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184861027 | chr3:159813462-159813463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs538102306 | chr3:159813507-159813508 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs556092534 | chr3:159813546-159813547 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs116281145 | chr3:159813550-159813551 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs77536303 | chr3:159813568-159813569 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs141567510 | chr3:159813655-159813656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs150888718 | chr3:159813659-159813660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139356237 | chr3:159813709-159813710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189377730 | chr3:159813719-159813720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574005619 | chr3:159813790-159813791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544844109 | chr3:159813849-159813850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541025116 | chr3:159813859-159813860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs75988219 | chr3:159813861-159813862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150009704 | chr3:159813898-159813899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533615722 | chr3:159813929-159813930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs180866945 | chr3:159813930-159813931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560665756 | chr3:159813963-159813964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs4680555 | chr3:159813969-159813970 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs549416242 | chr3:159814019-159814020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:159801000-159814600 | Weak transcription | Gastric | stomach |
2 | chr3:159807000-159825000 | Weak transcription | Pancreas | Pancrea |
3 | chr3:159808200-159813200 | Weak transcription | Esophagus | oesophagus |
4 | chr3:159812000-159812800 | Enhancers | HepG2 | liver |
5 | chr3:159812800-159816400 | Weak transcription | HepG2 | liver |
6 | chr3:159813200-159813400 | Enhancers | Esophagus | oesophagus |
7 | chr3:159813400-159815000 | Weak transcription | Esophagus | oesophagus |
8 | chr3:159814600-159815800 | Enhancers | Gastric | stomach |
9 | chr3:159815000-159816400 | Enhancers | Esophagus | oesophagus |
10 | chr3:159815200-159817000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr3:159815600-159816000 | Enhancers | Osteobl | bone |
12 | chr3:159815800-159816800 | Weak transcription | Gastric | stomach |
13 | chr3:159816000-159816600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |